The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Long-Term Survival for Patients With Non–Small-Cell Lung Cancer With Intratumoral Lymphoid Structures
Abstract
Purpose: It has been established that the immune system plays an important role in tumor rejection. There is also compelling evidence that immune responses can develop independently of secondary lymphoid organs in tertiary lymphoid structures. We studied the presence and the correlation of tertiary lymphoid structures with clinical outcome in non–small-cell lung cancer (NSCLC), as the prognostic value of these structures in patients with cancer had not yet been established. Patients and Methods: This retrospective study was performed by immunohistochemistry on paraffin-embedded tissue specimens from 74 patients with early-stage NSCLC. Results: Tertiary lymphoid structures were detected in some tumors but not in nontumoral lungs. Thus we called these structures tumor-induced bronchus-associated lymphoid tissue (Ti-BALT). As in lymph nodes, Ti-BALTs were composed of mature dendritic cell (DC)/T-cell clusters adjacent to B-cell follicles and had features of an ongoing immune response. Because the quantitative counting of Ti-BALT was difficult to achieve, we used mature DCs that homed exclusively in Ti-BALT as a specific marker of these structures. Univariate analysis showed that the density of mature DCs was highly associated with a favorable clinical outcome (overall, disease-specific, and disease-free survival), suggesting that Ti-BALT may participate in antitumoral immunity. The density of tumor-infiltrating lymphocytes, in particular, CD4+ and T-bet+ Th1 T cells, was profoundly decreased in tumors weakly infiltrated by mature DCs. Conclusion: The density of mature DCs was found to be a better predictor of clinical outcome than the other parameters tested. The number of tumor-infiltrating mature DCs may identify patients with early-stage NSCLC who have a high risk of relapse.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical Outcome
Galon, J., Costes, A., Sanchez-Cabo, F., Kirilovsky, A., Mlecnik, B., Lagorce-Pagès, C., Tosolini, M., Camus, M., Berger, A., Wind, P., et al. (2006) · Science · doi:10.1126/science.1129139 · Cited by 6,516
Self-citationRevisions in the International System for Staging Lung Cancer
Mountain, C. F. (1997) · Chest · doi:10.1378/chest.111.6.1710 · Cited by 4,565
Intratumoral T Cells, Recurrence, and Survival in Epithelial Ovarian Cancer
Zhang, L., Conejo-Garcia, J. R., Katsaros, D., Gimotty, P. A., Massobrio, M., Regnani, G., Makrigiannakis, A., Gray, H., Schlienger, K., Liebman, M. N., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa020177 · Cited by 3,397
The Three Es of Cancer Immunoediting
Dunn, G. P., Old, L. J., & Schreiber, R. D. (2004) · Annual Review of Immunology · doi:10.1146/annurev.immunol.22.012703.104803 · Cited by 3,072
Effector Memory T Cells, Early Metastasis, and Survival in Colorectal Cancer
Pagès, F., Berger, A., Camus, M., Sanchez-Cabo, F., Costes, A., Molidor, R., Mlecnik, B., Kirilovsky, A., Nilsson, M., Damotte, D., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051424 · Cited by 2,135 · cited 1×
“The density of tumorinfiltrating lymphocytes (TILs) with cytotoxic and memory phenotypes is highly predictive of good clinical outcome.(8-14) However, although prognosis is related to the homing of effector immune cells, it is still unclear where the activation of the specific immune response takes place: in the tumor…”
BackgroundSelf-citationInterferons, immunity and cancer immunoediting
Dunn, G. P., Koebel, C. M., & Schreiber, R. D. (2006) · Nature Reviews Immunology · doi:10.1038/nri1961 · Cited by 1,617
Clemente, C. G., Mihm, M. C., Bufalino, R., Zurrida, S., Collini, P., & Cascinelli, N. (1996) · Cancer · doi:10.1002/(sici)1097-0142(19960401)77:7<1303::aid-cncr12>3.0.co;2-5 · Cited by 1,171
The new World Health Organization classification of lung tumours
Brambilla, E., Travis, W. D., Colby, T. V., Corrin, B., & Shimosato, Y. (2001) · European Respiratory Journal · doi:10.1183/09031936.01.00275301 · Cited by 1,131
Role of inducible bronchus associated lymphoid tissue (iBALT) in respiratory immunity
Moyron-Quiroz, J. E., Rangel-Moreno, J., Kusser, K., Hartson, L., Sprague, F., Goodrich, S., Woodland, D. L., Lund, F. E., & Randall, T. D. (2004) · Nature Medicine · doi:10.1038/nm1091 · Cited by 821
Lymphoid organ development: from ontogeny to neogenesis
Drayton, D. L., Liao, S., Mounzer, R. H., & Ruddle, N. H. (2006) · Nature Immunology · doi:10.1038/ni1330 · Cited by 776
Schröder, A. E., Greiner, A., Seyfert, C., & Berek, C. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.1.221 · Cited by 434
Persistence and Responsiveness of Immunologic Memory in the Absence of Secondary Lymphoid Organs
Moyron-Quiroz, J. E., Rangel-Moreno, J., Hartson, L., Kusser, K., Tighe, M. P., Klonowski, K. D., Lefrançois, L., Cauley, L. S., Harmsen, A. G., Lund, F. E., et al. (2006) · Immunity · doi:10.1016/j.immuni.2006.08.022 · Cited by 261
Lymphoid neogenesis in chronic rejection: Evidence for a local humoral alloimmune response
Thaunat, O., Field, A.-C., Dai, J., Louedec, L., Patey, N., Bloch, M.-F., Mandet, C., Belair, M.-F., Bruneval, P., Meilhac, O., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0507223102 · Cited by 261
Wakabayashi, O., Yamazaki, K., Oizumi, S., Hommura, F., Kinoshita, I., Ogura, S., Dosaka‐Akita, H., & Nishimura, M. (2003) · Cancer Science · doi:10.1111/j.1349-7006.2003.tb01392.x · Cited by 252
Tschernig, T., & Pabst, R. (2000) · Pathobiology · doi:10.1159/000028109 · Cited by 228
Marchal-Sommé, J., Uzunhan, Y., Marchand-Adam, S., Valeyre, D., Soumelis, V., Crestani, B., & Soler, P. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.10.5735 · Cited by 179
Tefany, F. J., Barnetson, R. S., Halliday, G. M., McCarthy, S. W., & McCarthy, W. H. (1991) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12479662 · Cited by 159
Bronchus‐associated lymphoid tissue (BALT) in human fetal and infant lung
Gould, S. J., & Isaacson, P. G. (1993) · The Journal of Pathology · doi:10.1002/path.1711690209 · Cited by 138
Immunology and immunotherapy of colorectal cancer
Dalerba, P. D., Maccalli, C., Casati, C., Castelli, C., & Parmiani, G. (2003) · Critical Reviews in Oncology/Hematology · doi:10.1016/s1040-8428(02)00159-2 · Cited by 133
Kirk, C. J., Hartigan-O’Connor, D. J., & Mulé, J. J. (2001) · PubMed · Cited by 129
Regression in basal cell carcinoma: an immunohistochemical analysis
Hunt, M. J., Halliday, G. M., Weedon, D. D., Cooke, B. E., & Barnetson, R. S. (1994) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1994.tb06873.x · Cited by 124
Mature dendritic cells make clusters with T cells in the invasive margin of colorectal carcinoma
Suzuki, A., Masuda, A., Nagata, H., Kameoka, S., Kikawada, Y., Yamakawa, M., & Kasajima, T. (2001) · The Journal of Pathology · doi:10.1002/path.1018 · Cited by 117
Gause, A., Gundlach, K., Zdichavsky, M., Jacobs, G., Koch, B., Hopf, T., & Pfreundschuh, M. G. (1995) · European Journal of Immunology · doi:10.1002/eji.1830251010 · Cited by 65
Marmey, B., Boix, C., Barbaroux, J.-B., Dieu‐Nosjean, M., Diebold, J., Audouin, J., Fridman, W. H., Mueller, C. G., & Molina, T. J. (2005) · Human Pathology · doi:10.1016/j.humpath.2005.09.016 · Cited by 45
Self-citationGeneration of experimental allergic airways inflammation in the absence of draining lymph nodes
Gajewska, B., Álvarez, D., Vidric, M., Goncharova, S. I., Stämpfli, M. R., Coyle, A. J., Gutierrez-Ramos, J.-C., & Jordana, M. (2001) · Journal of Clinical Investigation · doi:10.1172/jci12627 · Cited by 39
Tesar, B. M., Chalasani, G., Diggs, L., Baddoura, F. K., Lakkis, F. G., & Goldstein, D. R. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.7.4377 · Cited by 22
CD4+ T lymphocyte infiltration correlates with regression of a UV-induced squamous cell carcinoma
Patel, A., Halliday, G. M., & Barnetson, R. S. (1995) · Journal of Dermatological Science · doi:10.1016/0923-1811(94)00344-e · Cited by 19
Chemokines in the Biology of Lung Cancer
Arenberg, D. A. (2006) · Journal of Thoracic Oncology · doi:10.1016/s1556-0864(15)31582-3 · Cited by 12
Cited by
The immune contexture in human tumours: impact on clinical outcome
Fridman, W. H., Pagès, F., Sautès-Fridman, C., & Galon, J. (2012) · Nature reviews. Cancer · doi:10.1038/nrc3245 · Cited by 4,981
Self-citationFundamental Mechanisms of Immune Checkpoint Blockade Therapy
Wei, S. C., Duffy, C. R., & Allison, J. P. (2018) · Cancer Discovery · doi:10.1158/2159-8290.cd-18-0367 · Cited by 3,088
Mechanism-driven biomarkers to guide immune checkpoint blockade in cancer therapy
Topalian, S. L., Taube, J. M., Anders, R. A., & Pardoll, D. M. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.36 · Cited by 2,733
The immune contexture in cancer prognosis and treatment
Fridman, W. H., Zitvogel, L., Sautès–Fridman, C., & Kroemer, G. (2017) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2017.101 · Cited by 2,263
Self-citationRoles of the immune system in cancer: From tumor initiation to metastatic progression
Gonzalez, H., Hagerling, C., & Werb, Z. (2018) · Genes & Development · doi:10.1101/gad.314617.118 · Cited by 2,111
Metadata
- Authors
- Dieu-Nosjean, M.-C., Antoine, M., Danel, C., Heudes, D., Wislez, M., Poulot, V., Rabbe, N., Laurans, L., Tartour, E., de Chaisemartin, L., Lebecque, S., Fridman, W.-H., & Cadranel, J.
- Venue
- Journal of Clinical Oncology
- Published
- 2008-09-20
- Volume
- 26
- Issue
- 27
- Pages
- 4410-4417
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2110252240
- Cited by
- 1,031
- References
- 28
- FWCI
- 12.94
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.